The National Prostate Cancer Audit (NPCA) evaluates patterns of care and outcomes and reports on diagnosis, treatment and outcomes for men diagnosed with prostate cancer in England and Wales. As much as possible, we compare practice and outcomes against national guidance and quality standards, including those from the National Institute for Health and Care Excellence (NICE) to help NHS organisations benchmark their prostate cancer care against measurable standards and to identify unwarranted variation in measures of processes and outcomes.
This report is an audit of care received by people diagnosed or treated with prostate cancer between 1 September 2022 and 31 March 2025 in England and Wales. In addition, a description of national time trends in diagnoses, treatments, and survival outcomes between 1 January 2015 and 31 December 2025 in England and 1 September 2022 and 31 December 2024 in Wales.
We present results from seven key performance indicators (PIs) in the management of prostate cancer, as well as the variation in performance among providers in England and Wales. Furthermore, we outline five recommendations for providers to help improve their performance, showcase provider-level data and describe results from our outlier process. We also aim to align the PIs with our Quality Improvement Plan, last published in November 2025 and reviewed annually.
Individual provider results and reports are available, enabling regional and national comparisons to support local QI.